Status:
COMPLETED
Introduction and Influence of Total Mesorectal Excision (TME) in the Treatment of Rectal Cancer
Lead Sponsor:
Insel Gruppe AG, University Hospital Bern
Conditions:
Rectal Cancer
Eligibility:
All Genders
16+ years
Brief Summary
Total mesorectal excision (TME) is a rather new operation technique in the treatment of rectal cancer. It is known to reduce the rate of local recurrences. However, the influence on long-term survival...
Detailed Description
Background The TME technique for rectal cancer surgery was introduced in our department in summer 1995. TME is known to reduce the rate of local recurrences. However, its influence on long-term survi...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- adenocarcinoma of the rectum
- 16 years and older
Exclusion
Key Trial Info
Start Date :
January 1 1993
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2001
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT00910143
Start Date
January 1 1993
End Date
December 1 2001
Last Update
May 29 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of visceral and transplant surgery, Bern University Hospital
Bern, Switzerland, 3010